Q2 2024 Holdings
Filed 2024-08-14 | 57 holdings | $1.2B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-08-27) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $185.4M | 2,000,000 | 14.9% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $79.0M | 500,000 | 6.4% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $76.7M | 2,000,000 | 6.2% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $59.7M | 1,700,000 | 4.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $58.1M | 135,000 | 4.7% |
| Merus N V | COM | N5749R100 | $50.3M | 850,000 | 4.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $46.6M | 1,200,000 | 3.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $43.2M | 1,100,000 | 3.5% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $41.7M | 925,000 | 3.4% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $35.2M | 5,150,000 | 2.8% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $34.7M | 3,208,875 | 2.8% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $34.4M | 950,000 | 2.8% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $33.0M | 750,000 | 2.7% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $31.4M | 750,000 | 2.5% |
| Xencor Inc(XNCR) | COM | 98401F105 | $28.4M | 1,500,000 | 2.3% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $28.0M | 1,476,061 | 2.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $23.7M | 150,000 | 1.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $18.8M | 800,000 | 1.5% |
| Structure Therapeutics Inc(GPCR)Call | SPONSORED ADS | 86366E106 | $17.7M | 450,000 | 1.4% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $16.9M | 5,032,501 | 1.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $16.2M | 3,300,000 | 1.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $15.3M | 400,000 | 1.2% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $15.2M | 575,000 | 1.2% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $14.8M | 195,000 | 1.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $14.6M | 375,000 | 1.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $14.3M | 300,000 | 1.1% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $14.2M | 1,050,000 | 1.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $13.9M | 5,900,000 | 1.1% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $13.9M | 595,000 | 1.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $13.5M | 575,000 | 1.1% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $11.3M | 1,200,000 | 0.9% |
| Cybin Inc(CYBNEUR) | COM | 23256X100 | $10.8M | 40,000,000 | 0.9% |
| Skye Bioscience Inc(SKYE) | COM NEW | 83086J200 | $10.4M | 1,301,518 | 0.8% |
| Elevation Oncology Inc | COM | 28623U101 | $10.4M | 3,850,000 | 0.8% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $9.4M | 265,000 | 0.8% |
| Fulcrum Therapeutics Inc(FULC)Call | COM | 359616109 | $9.3M | 1,500,000 | 0.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $8.7M | 250,000 | 0.7% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $8.5M | 1,300,000 | 0.7% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $8.3M | 2,800,000 | 0.7% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $7.5M | 350,000 | 0.6% |
| Annexon Inc(ANNX)Call | COM | 03589W102 | $7.4M | 1,500,000 | 0.6% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $7.0M | 1,159,030 | 0.6% |
| Avalo Therapeutics Inc(AVTX)A | COM NEW | 05338F306 | $6.7M | 539,079 | 0.5% |
| Lineage Cell Therapeutics in(LCTX) | COM | 53566P109 | $4.7M | 4,700,000 | 0.4% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $4.7M | 3,000,000 | 0.4% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $4.6M | 500,000 | 0.4% |
| Rapport Therapeutics Inc(RAPP)A | COM | 75383L102 | $4.4M | 208,910 | 0.4% |
| Nextcure Inc | COM | 65343E108 | $4.0M | 2,500,000 | 0.3% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $2.9M | 300,000 | 0.2% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $2.9M | 2,900,000 | 0.2% |